Loading…
Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas
Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples fro...
Saved in:
Published in: | British journal of cancer 1998-01, Vol.77 (2), p.297-304 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163 |
---|---|
cites | |
container_end_page | 304 |
container_issue | 2 |
container_start_page | 297 |
container_title | British journal of cancer |
container_volume | 77 |
creator | Protiva, P Sordat, I Chaubert, P Saraga, E Trén-Thang, C Sordat, B Blum, AL Dorta, G |
description | Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples from control subjects were histopathologically analysed for dysplasia grade and tissue type, urokinase plasminogen activator levels and plasminogen activator inhibitor type 1 (PAI-1) using immunosorbent methods. Plasminogen activation and urokinase-mediated proteolytic activity levels were assessed using in situ zymography. Plasminogen activation and tissue-type activator levels were lower in adenomas than in mucosae (P < 0.001). PAI-1 concentration and urokinase levels were higher in adenomas than in mucosae (P < 0.001 and P < 0.001 respectively). In adenomas, urokinase concentration increased in parallel with PAI-1, but only the urokinase levels correlated with the dysplasia grade (P < 0.01). Thus, the alterations in plasminogen activation correlated with epithelial cell dysplasia grading. In the mucosa to adenoma transition, a marked decrease in tissue-type plasminogen activator occurred. In adenomas, this decrease was accompanied by a concomitant increase in urokinase and PAI-1. The urokinase level only continued to rise in parallel with the dysplasia grade. Resulting protease-antiprotease imbalance in high-grade dysplasia may represent the phenotypic change associated with malignant transformation and invasive behaviour. |
doi_str_mv | 10.1038/bjc.1998.46 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2151227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79682513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163</originalsourceid><addsrcrecordid>eNp1kUtv1DAUhS0EKkNhxRqRBWIDGfxIJvamUlXxkiqxgbV149ykHjn2YDtF_fc4zGgECza2rPP53GMfQl4yumVUyA_93myZUnLb7B6RDWsFr5nk3WOyoZR2NVWcPiXPUtqXo6KyuyAXqtkxStmGzNcuY4Rsg0-V9dXBQZqtDxP6Cky293-kyoQY0UHG6pfNdxUeyorOgqsMOlcND2m9aKGaIgzWT6uVCS5ENLlAMKAPM6Tn5MkILuGL035Jfnz6-P3mS3377fPXm-vb2jSK5no0gis54thgPzTc9HwHHR1aoaQaJW97iULgODAjpcS2xVFB31FALiQTbCcuydXR97D0Mw4GfY7g9CHaGeKDDmD1v4q3d3oK95qzlnHeFYO3J4MYfi6Ysp5tWp8KHsOSdKd2JQcTBXx3BE0MKUUcz0MY1Ws7urSj13Z0s-Z69XeuM3uqo-hvTjokA26M4I1NZ4yXbLRtCvb-iKWi-Amj3ocl-vKj_5n6-oh7yEvEs11hVqQQvwF3nrUh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79682513</pqid></control><display><type>article</type><title>Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas</title><source>PMC (PubMed Central)</source><creator>Protiva, P ; Sordat, I ; Chaubert, P ; Saraga, E ; Trén-Thang, C ; Sordat, B ; Blum, AL ; Dorta, G</creator><creatorcontrib>Protiva, P ; Sordat, I ; Chaubert, P ; Saraga, E ; Trén-Thang, C ; Sordat, B ; Blum, AL ; Dorta, G</creatorcontrib><description>Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples from control subjects were histopathologically analysed for dysplasia grade and tissue type, urokinase plasminogen activator levels and plasminogen activator inhibitor type 1 (PAI-1) using immunosorbent methods. Plasminogen activation and urokinase-mediated proteolytic activity levels were assessed using in situ zymography. Plasminogen activation and tissue-type activator levels were lower in adenomas than in mucosae (P < 0.001). PAI-1 concentration and urokinase levels were higher in adenomas than in mucosae (P < 0.001 and P < 0.001 respectively). In adenomas, urokinase concentration increased in parallel with PAI-1, but only the urokinase levels correlated with the dysplasia grade (P < 0.01). Thus, the alterations in plasminogen activation correlated with epithelial cell dysplasia grading. In the mucosa to adenoma transition, a marked decrease in tissue-type plasminogen activator occurred. In adenomas, this decrease was accompanied by a concomitant increase in urokinase and PAI-1. The urokinase level only continued to rise in parallel with the dysplasia grade. Resulting protease-antiprotease imbalance in high-grade dysplasia may represent the phenotypic change associated with malignant transformation and invasive behaviour.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.1998.46</identifier><identifier>PMID: 9461001</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Adenoma - enzymology ; Adenoma - pathology ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Colorectal Neoplasms - enzymology ; Colorectal Neoplasms - pathology ; Drug Resistance ; Enzyme Activation ; Epidemiology ; Epithelial Cells - enzymology ; experimental-oncology ; Female ; Fibrinolysin - metabolism ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Male ; Medical sciences ; Middle Aged ; Molecular Medicine ; Oncology ; Plasminogen - metabolism ; Plasminogen Activator Inhibitor 1 - metabolism ; Plasminogen Activators - metabolism ; Prospective Studies ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tissue Plasminogen Activator - metabolism ; Tumors ; Urokinase-Type Plasminogen Activator - metabolism</subject><ispartof>British journal of cancer, 1998-01, Vol.77 (2), p.297-304</ispartof><rights>Cancer Research Campaign 1998</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151227/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151227/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4022,27922,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2122054$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9461001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Protiva, P</creatorcontrib><creatorcontrib>Sordat, I</creatorcontrib><creatorcontrib>Chaubert, P</creatorcontrib><creatorcontrib>Saraga, E</creatorcontrib><creatorcontrib>Trén-Thang, C</creatorcontrib><creatorcontrib>Sordat, B</creatorcontrib><creatorcontrib>Blum, AL</creatorcontrib><creatorcontrib>Dorta, G</creatorcontrib><title>Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples from control subjects were histopathologically analysed for dysplasia grade and tissue type, urokinase plasminogen activator levels and plasminogen activator inhibitor type 1 (PAI-1) using immunosorbent methods. Plasminogen activation and urokinase-mediated proteolytic activity levels were assessed using in situ zymography. Plasminogen activation and tissue-type activator levels were lower in adenomas than in mucosae (P < 0.001). PAI-1 concentration and urokinase levels were higher in adenomas than in mucosae (P < 0.001 and P < 0.001 respectively). In adenomas, urokinase concentration increased in parallel with PAI-1, but only the urokinase levels correlated with the dysplasia grade (P < 0.01). Thus, the alterations in plasminogen activation correlated with epithelial cell dysplasia grading. In the mucosa to adenoma transition, a marked decrease in tissue-type plasminogen activator occurred. In adenomas, this decrease was accompanied by a concomitant increase in urokinase and PAI-1. The urokinase level only continued to rise in parallel with the dysplasia grade. Resulting protease-antiprotease imbalance in high-grade dysplasia may represent the phenotypic change associated with malignant transformation and invasive behaviour.</description><subject>Adenoma - enzymology</subject><subject>Adenoma - pathology</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Colorectal Neoplasms - enzymology</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Drug Resistance</subject><subject>Enzyme Activation</subject><subject>Epidemiology</subject><subject>Epithelial Cells - enzymology</subject><subject>experimental-oncology</subject><subject>Female</subject><subject>Fibrinolysin - metabolism</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Plasminogen - metabolism</subject><subject>Plasminogen Activator Inhibitor 1 - metabolism</subject><subject>Plasminogen Activators - metabolism</subject><subject>Prospective Studies</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tissue Plasminogen Activator - metabolism</subject><subject>Tumors</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNp1kUtv1DAUhS0EKkNhxRqRBWIDGfxIJvamUlXxkiqxgbV149ykHjn2YDtF_fc4zGgECza2rPP53GMfQl4yumVUyA_93myZUnLb7B6RDWsFr5nk3WOyoZR2NVWcPiXPUtqXo6KyuyAXqtkxStmGzNcuY4Rsg0-V9dXBQZqtDxP6Cky293-kyoQY0UHG6pfNdxUeyorOgqsMOlcND2m9aKGaIgzWT6uVCS5ENLlAMKAPM6Tn5MkILuGL035Jfnz6-P3mS3377fPXm-vb2jSK5no0gis54thgPzTc9HwHHR1aoaQaJW97iULgODAjpcS2xVFB31FALiQTbCcuydXR97D0Mw4GfY7g9CHaGeKDDmD1v4q3d3oK95qzlnHeFYO3J4MYfi6Ysp5tWp8KHsOSdKd2JQcTBXx3BE0MKUUcz0MY1Ws7urSj13Z0s-Z69XeuM3uqo-hvTjokA26M4I1NZ4yXbLRtCvb-iKWi-Amj3ocl-vKj_5n6-oh7yEvEs11hVqQQvwF3nrUh</recordid><startdate>199801</startdate><enddate>199801</enddate><creator>Protiva, P</creator><creator>Sordat, I</creator><creator>Chaubert, P</creator><creator>Saraga, E</creator><creator>Trén-Thang, C</creator><creator>Sordat, B</creator><creator>Blum, AL</creator><creator>Dorta, G</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199801</creationdate><title>Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas</title><author>Protiva, P ; Sordat, I ; Chaubert, P ; Saraga, E ; Trén-Thang, C ; Sordat, B ; Blum, AL ; Dorta, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adenoma - enzymology</topic><topic>Adenoma - pathology</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Colorectal Neoplasms - enzymology</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Drug Resistance</topic><topic>Enzyme Activation</topic><topic>Epidemiology</topic><topic>Epithelial Cells - enzymology</topic><topic>experimental-oncology</topic><topic>Female</topic><topic>Fibrinolysin - metabolism</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Plasminogen - metabolism</topic><topic>Plasminogen Activator Inhibitor 1 - metabolism</topic><topic>Plasminogen Activators - metabolism</topic><topic>Prospective Studies</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tissue Plasminogen Activator - metabolism</topic><topic>Tumors</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Protiva, P</creatorcontrib><creatorcontrib>Sordat, I</creatorcontrib><creatorcontrib>Chaubert, P</creatorcontrib><creatorcontrib>Saraga, E</creatorcontrib><creatorcontrib>Trén-Thang, C</creatorcontrib><creatorcontrib>Sordat, B</creatorcontrib><creatorcontrib>Blum, AL</creatorcontrib><creatorcontrib>Dorta, G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Protiva, P</au><au>Sordat, I</au><au>Chaubert, P</au><au>Saraga, E</au><au>Trén-Thang, C</au><au>Sordat, B</au><au>Blum, AL</au><au>Dorta, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>1998-01</date><risdate>1998</risdate><volume>77</volume><issue>2</issue><spage>297</spage><epage>304</epage><pages>297-304</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Proteases are important for neoplastic invasion but a specific role for the plasminogen activator system in the progression of colorectal epithelial dysplasia to adenomatous lesions remains unclear. Consecutive tissue cryosections of 51 adenomas, 49 distant mucosa samples and five mucosa samples from control subjects were histopathologically analysed for dysplasia grade and tissue type, urokinase plasminogen activator levels and plasminogen activator inhibitor type 1 (PAI-1) using immunosorbent methods. Plasminogen activation and urokinase-mediated proteolytic activity levels were assessed using in situ zymography. Plasminogen activation and tissue-type activator levels were lower in adenomas than in mucosae (P < 0.001). PAI-1 concentration and urokinase levels were higher in adenomas than in mucosae (P < 0.001 and P < 0.001 respectively). In adenomas, urokinase concentration increased in parallel with PAI-1, but only the urokinase levels correlated with the dysplasia grade (P < 0.01). Thus, the alterations in plasminogen activation correlated with epithelial cell dysplasia grading. In the mucosa to adenoma transition, a marked decrease in tissue-type plasminogen activator occurred. In adenomas, this decrease was accompanied by a concomitant increase in urokinase and PAI-1. The urokinase level only continued to rise in parallel with the dysplasia grade. Resulting protease-antiprotease imbalance in high-grade dysplasia may represent the phenotypic change associated with malignant transformation and invasive behaviour.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>9461001</pmid><doi>10.1038/bjc.1998.46</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0920 |
ispartof | British journal of cancer, 1998-01, Vol.77 (2), p.297-304 |
issn | 0007-0920 1532-1827 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2151227 |
source | PMC (PubMed Central) |
subjects | Adenoma - enzymology Adenoma - pathology Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research Colorectal Neoplasms - enzymology Colorectal Neoplasms - pathology Drug Resistance Enzyme Activation Epidemiology Epithelial Cells - enzymology experimental-oncology Female Fibrinolysin - metabolism Gastroenterology. Liver. Pancreas. Abdomen Humans Male Medical sciences Middle Aged Molecular Medicine Oncology Plasminogen - metabolism Plasminogen Activator Inhibitor 1 - metabolism Plasminogen Activators - metabolism Prospective Studies Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tissue Plasminogen Activator - metabolism Tumors Urokinase-Type Plasminogen Activator - metabolism |
title | Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T01%3A07%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alterations%20in%20plasminogen%20activation%20correlate%20with%20epithelial%20cell%20dysplasia%20grading%20in%20colorectal%20adenomas&rft.jtitle=British%20journal%20of%20cancer&rft.au=Protiva,%20P&rft.date=1998-01&rft.volume=77&rft.issue=2&rft.spage=297&rft.epage=304&rft.pages=297-304&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/bjc.1998.46&rft_dat=%3Cproquest_pubme%3E79682513%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c490t-fc3298fef4ebd42cb26a70d53989f825b8e33efd1c888e55ef9ab70ae23813163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79682513&rft_id=info:pmid/9461001&rfr_iscdi=true |